Screening of tumor antigens and immunogenic cell death landscapes of prostate adenocarcinoma for exploration of mRNA vaccine

• Váldodahkkit: Guopeng Yu (Dahkki), Yuansheng Lin (Dahkki), Jianqing Wang (Dahkki), Lin Zhou (Dahkki), Yingying Lu (Dahkki), Xiang Fei (Dahkki), Xin Gu (Dahkki), Shangqing Song (Dahkki), Jiangyi Wang (Dahkki), Yushan Liu (Dahkki), Qing Yang (Dahkki), Ming Zhan (Dahkki), Seung-Yong Seo (Dahkki), Bin Xu (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Background In this study, effective antigens of mRNA vaccine were excavated from the perspective of ICD, and ICD subtypes of PRAD were further distinguished to establish an ICD landscape, thereby determining suitable vaccine recipients.Research design and methods TCGA and MSKCC databases were applie...